Overview
GLP-1.2 Nasal Spray features Tirzepatide, a synthetic peptide that serves as a dual agonist for the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Engineered with a sequence of 39 amino acids, Tirzepatide is formulated to enhance stability and bioactivity in laboratory settings, making it an essential component for scientific inquiry into metabolic signaling pathways.
Key Features
- Research-grade formulation for laboratory use.
- Contains Tirzepatide, a dual receptor agonist.
- Targeted for metabolic studies and investigations.
- Designed for enhanced stability and bioactivity.
- Convenient nasal spray delivery system.
Specifications
| Component | Description |
|---|---|
| Active Ingredient | Tirzepatide |
| Form | Nasal Spray |
| Concentration | Varies |
| Volume | Varies |
FAQ
What is Tirzepatide?
Tirzepatide is a synthetic peptide that acts on GLP-1 and GIP receptors, making it a focus of research for its potential benefits in metabolic regulation.
How should I store GLP-1.2 Nasal Spray?
Store the nasal spray in a cool, dry place away from direct sunlight and heat to maintain its stability and efficacy.
Is this product intended for human use?
No, GLP-1.2 Nasal Spray is designed strictly for research purposes and should not be used for human consumption.
Explore GLP-1.2 Nasal Spray today and advance your research on metabolic pathways. Purchase now to add this valuable tool to your laboratory supplies.
Related Products
Browse more in Nasal Sprays.














